FWBI
First Wave BioPharma Inc

12,032
Loading...
Loading...
News
all
press releases
FY2023 EPS Estimates for First Wave BioPharma, Inc. Boosted by Analyst (NASDAQ:FWBI)
First Wave BioPharma, Inc. (NASDAQ:FWBI Free Report) HC Wainwright boosted their FY2023 earnings estimates for shares of First Wave BioPharma in a report released on Monday, March...
Ticker Report·1y ago
News Placeholder
More News
News Placeholder
First Wave BioPharma reinstated with a Neutral at H.C. Wainwright
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease
First Wave BioPharma acquires ImmunogenX, focusing on advancing GI pipeline. James Sapirstein remains Chairman & CEO, with Jack Syage as President & COO.' read more...
Benzinga·2y ago
News Placeholder
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease James Sapirstein, Chairman and Chief Executive Officer, to continue leading First Wave...
Globe Newswire·2y ago
News Placeholder
First Wave BioPharma to Participate In 'Fireside Chat' at the 36th Annual Roth Conference
BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing...
Globe Newswire·2y ago
News Placeholder
First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
BOCA RATON, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing...
Globe Newswire·2y ago
News Placeholder
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing in...
Globe Newswire·2y ago
News Placeholder
First Wave BioPharma (NASDAQ:FWBI) Trading Down 3%
Shares of First Wave BioPharma, Inc. (NASDAQ:FWBI Get Free Report) traded down 3% during mid-day trading on Thursday . The company traded as low as $4.95 and last traded at $5.14. 159,133...
Zolmax·2y ago
News Placeholder
First Wave BioPharma to Present at the DealFlow MicroCap Conference
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing in...
Globe Newswire·2y ago
News Placeholder
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing in...
Globe Newswire·2y ago

Latest FWBI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.